Gangliosides and Tumors
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-8552-4_6
Reference177 articles.
1. No authors listed (2015) Dinutuximab approved for high-risk neuroblastoma. Cancer Discov 5:OF5
2. Dhillon S (2015) Dinutuximab: first global approval. Drugs 75:923–927
3. Gabri MR, Cacciavillano W, Chantada GL, Alonso DF (2016) Racotumomab for treating lung cancer and pediatric refractory malignancies. Expert Opin Biol Ther 16:573–578
4. Hakomori SI, Murakami WT (1968) Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines. Proc Natl Acad Sci U S A 59:254–261
5. Hakomori SI (2010) Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett 584:1901–1906
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of tumor cell sialylation in pancreatic cancer progression;Advances in Cancer Research;2023
2. Gangliosides and Their Role in Multilineage Differentiation of Mesenchymal Stem Cells;Biomedicines;2022-12-02
3. Regulation of signal transduction by gangliosides in lipid rafts: focus on GM3 – IR and GM1 – TrkA interactions;FEBS Letters;2022-11-11
4. Who moves the sphinx? An overview of intracellular sphingolipid transport;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2021-11
5. Sphingolipid metabolism in the development and progression of cancer: one cancer's help is another's hindrance;Molecular Oncology;2021-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3